IMRX

Latest SEC Filings & News for IMRX

1 most recent filing and news item mentioning IMRX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/IMRX/news?limit=20"

Pull IMRX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 5, 2026Positive

Immuneering Reports Q2 2026 Financial Results and Key Updates

Immuneering Corp (IMRX) reported its Q2 2026 financials. The company announced positive interim Phase 2a pancreatic cancer data and is dosing patients in its pivotal Phase 3 MAPKeeper 301 trial.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.